Literature DB >> 35864816

Preoperative fibrinogen before the repair of type A aortic dissection: Are the results too good to be true?: Editorial comment on: Li J, Wu Q, Tang M, Shen Y, Qiu Z, Chen X, Chen X, Chen L. Preoperative clinical application of human fibrinogen in patients with acute Stanford type A aortic dissection: A single-center retrospective study. Journal of Cardiac Surgery. In press.

Frank W Sellke1.   

Abstract

Entities:  

Keywords:  aortic; aortic dissection; aortic surgery; fibrinogen; transfusion

Mesh：

Substances：

Year:  2022        PMID： 35864816      PMCID： PMC9444943          DOI： 10.1111/jocs.16760

Source DB:  PubMed          Journal:  J Card Surg        ISSN： 0886-0440            Impact factor:   1.778


× No keyword cloud information.
  4 in total

1.  Fibrinogen concentrate reduces intraoperative bleeding when used as first-line hemostatic therapy during major aortic replacement surgery: results from a randomized, placebo-controlled trial.

Authors:  Niels Rahe-Meyer; Alexander Hanke; Dirk S Schmidt; Christian Hagl; Maximilian Pichlmaier
Journal:  J Thorac Cardiovasc Surg       Date:  2013-03       Impact factor: 5.209

2.  Preoperative clinical application of human fibrinogen in patients with acute Stanford type A aortic dissection: A single-center retrospective study.

Authors:  Jiahui Li; Qingsong Wu; Mirong Tang; Yue Shen; Zhihuang Qiu; Xiaodong Chen; Xingfeng Chen; Liangwan Chen
Journal:  J Card Surg       Date:  2022-07-21       Impact factor: 1.778

3.  Fibrinogen Concentrate in Cardiovascular Surgery: A Meta-analysis of Randomized Controlled Trials.

Authors:  Jing-Yi Li; Junsong Gong; Fang Zhu; Jessica Moodie; Amy Newitt; Lavanya Uruthiramoorthy; Davy Cheng; Janet Martin
Journal:  Anesth Analg       Date:  2018-09       Impact factor: 5.108

4.  Fibrinogen concentrate administration attributes to significant reductions of blood loss and transfusion requirements in thoracic aneurysm repair.

Authors:  Koji Yamamoto; Akihiko Usui; Junki Takamatsu
Journal:  J Cardiothorac Surg       Date:  2014-05-19       Impact factor: 1.637
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.